This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0339U for SelectMDx® for Prostate Cancer from MDxHealth® Inc. Using a urine specimen, the test evaluates the activity (gene expression) of two genes: HOXC6 and DLX1. An algorithmic analysis of the findings reports a probability score for the likelihood that the patient has high–grade prostate cancer.
For clinical responsibility, terminology, tips and additional info
start codify free trial.